Disseminated AIDS-associated Burkitt’s Lymphoma Demonstrated on FDG PET/CT

Clinical Image

Austin J HIV/AIDS Res. 2014;1(2): 2.

Disseminated AIDS-associated Burkitt’s Lymphoma Demonstrated on FDG PET/CT

Yiyan Liu*

Department of Radiology, New Jersey Medical School, USA

*Corresponding author: Yiyan Liu, Nuclear Medicine Service, Department of Radiology, University Hospital, H-141, 150 Bergen Street, Newark, NJ 07103, USA

Received: October 20, 2014; Accepted: November 25, 2014; Published: November 27, 2014

A 40-year-old woman with history of HIV infection and AIDS had vaginal bleeding. A cervical biopsy suggested Burkitt’s lymphoma. Which imaging modality is best for initial staging? The choice is metabolic imaging F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG PET/CT). Today FDG PET/CT has gained widespread clinical applications in oncology, and it is accepted as a standard care in most malignancies. FDG is an analog of glucose and is used as a tracer of glycolysis. Malignant tissue and cells often demonstrate increased rate of glycolysis for rapid proliferation, due to increased numbers of glucose transporter protein and increased intracellular hexokinase and phosphofructokinase levels [1,2]. The intensity of FDG is proportional to the rate of glycolysis, therefore is potentially semi-quantitative with standardized uptake value (SUV). FDG PET/CT has a significant advance over traditional images in demonstrating metabolic changes which often precede anatomic changes, and routine whole-body requisition [3,4].

Burkitt’s lymphoma is a highly aggressive B-cell non- Hodgkin lymphoma. The disease is characterized by chromosomal rearrangements involving the c-myc proto-oncogene which results in its inappropriate expression [5]. Is there any difference of incidences of Burkitt’s lymphoma in HIV-infected and non-HIV infected populations? Yes. Burkitt’s lymphoma accounts for only 1-3% of lymphomas in HIV-seronegative adults, but this figure rises to 15-40% for AIDS-related lymphomas [6,7]. Burkitt’s lymphoma is strongly associated with HIV infection, especially in developing countries [8,9].

What are findings of FDG PET/CT in the case? As seen in Figure 1-4, there is a bulky cervical mass with intense uptake with parametrial and posterior vaginal invasion. There are multiple sites of lymphadenopathy, the most prominent in the pelvis. There are peritoneal implants. Incidentally noted is FDG avid thyroid lesion. All are consistent with disseminated and stage IV lymphomatous disease.